Recruiting Brain Cancer Studies in Vienna
Antiangiogenic Therapy for Children with Recurrent Medulloblastoma, Ependymoma and ATRT
Patients with relapsed medulloblastoma, ependymoma and ATRT have a very poor prognosis whether treated with conventional chemotherapy, high-dose chemotherapy with stem cell rescue, irradiation or comb...
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
The objective of this study is to determine the safety and tolerability of vorasidenib in combination with temozolomide (TMZ) and to establish the recommended combination dose (RCD) of vorasidenib. Th...
About Brain Cancer Clinical Trials in Vienna
Brain cancer includes tumors that originate in the brain (primary) or spread from other areas (metastatic). Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Treatment typically combines surgery, radiation, and chemotherapy, with immunotherapy trials underway.
There are currently 2 brain cancer clinical trials recruiting participants in Vienna, . These studies are seeking a combined 142 participants. Research is being sponsored by Medical University of Vienna, Institut de Recherches Internationales Servier. Clinical trial participation is free and participants receive study-related medical care at no cost.
Brain Cancer Clinical Trials in Vienna — FAQ
Are there brain cancer clinical trials in Vienna?
Yes, there are 2 brain cancer clinical trials currently recruiting in Vienna, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Vienna?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vienna research site will contact you about next steps.
Are clinical trials in Vienna free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vienna studies also compensate for your time and travel.
What brain cancer treatments are being tested?
The 2 active trials in Vienna are testing new therapies including novel drugs, biologics, and treatment approaches for brain cancer.
Data updated March 2, 2026 from ClinicalTrials.gov